Gilbert syndrome: Literature review directed at diagnostic methods




Gilbert syndrome; Hyperbilirubinemia; UGT1A1.


Gilbert syndrome is a condition of dominant autosomal inheritance with incomplete penetrance characterized by unconjugated, hyperbilirubinemia in a slightly increased form, chronic and not associated with any liver disease or hemolysis. The carriers of the syndrome have bilirubin glucuronidation disorder and consequent indirect hyperbilirubinemia due to a mutation in the UGT1A1 gene. It usually manifests between the post-pubertal period up to the age of 20 years. The symptoms usually appear after physical exercise, fasting periods, and in infectious conditions. Most patients are asymptomatic, and in some the only sign is jaundice. The diagnosis is given by the elevation of serum bilirubin, rarely exceeds 3 mg/dL, besides anamnesis and directed physical examination. On physical examination, it is essential to investigate the presence of telangiectasia (vascular spider), Dupuytren's contracture (claw hand), gynecomastia, and ascites in order to rule out cirrhosis of the liver. It is also necessary to make sure there is no palpable mass in the right upper quadrant, as this could suggest biliary pathology justifying obstruction jaundice. Gilbert's syndrome has a benign character with favorable prognosis and evolution, being the clinical diagnosis the most important one.


Abnet, C., Fagundes, R., Strickland, P., Kamangar, F., Roth, M. & Taylor, P. et al. (2007). The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil. Carcinogenesis. 28(1):112-117.

Bailey, A., Robinson, D. & Dawson, A. M. (1976). Does Gilbert’s disease exist? The Lancet. 1977;310(8033):363.

Ben, M. D., Gazzin, S. & Tiribelli, C. (2014). Neonatal hyperbilirubinemia. Ben et al. Italian Journal of Pediatrics. 40(Suppl 2):A10.

Borlak et al. (2000). Molecular Diagnosis of a Familial Nonhemolytic Hyperbilirubinemia (Gilbert’s Syndrome) in Healthy Subjects. Hepatology. (4):792-795.

Bulmer, A. C., Verkade, H. J. & Wagner, K. H. (2013). Bilirubin and beyond: A review of lipid status in Gilbert’s syndrome and its relevance to cardiovascular disease protection. Prog Lipid Res. 52(2):193-205.

Canu, G., Minucci, A., Zuppi, C. & Capoluongo, E. (2013). Gilbert and Crigler Najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database. Blood Cells Mol Dis. 50(4):273-80.

Claridge, L., Armstrong, M., Booth, C. & Gill, P. (2011). Gilbert's syndrome. BMJ. 2293-d2293.

Dabke, P., Colah, R., Ghosh, K. & Nadkarni, A. (2013). Role of co-inherited Gilbert syndrome on hyperbilirubinemia in Indian beta thalassemia patients. Hematology. 19(7):388-392.

Ehmer, U., Kalthoff, S., Fakundiny, B., Pabst, B., Freiberg, N. & Naumann, R. et al. (2012). Gilbert syndrome redefined: A complex genetic haplotype influences the regulation of glucuronidation. Hepatology. 55(6):1912-1921.

Esteitie, R. (2015). Fundamentos de pesquisa clínica. Porto Alegre, Brasil: AMGH Editora LTDA.

Felsher et al. (1970). The reciprocal relation between calorie intake and the degree of hyperbilirubinemia in Gilbert’s syndrome. The New England Journal of

Medicine. 283 (4): 170-172.

Fevery, J. (2008). Bilirubin in clinical practice: a review. Liver International. 28(5):592-605.

Flores, E. V., Rodriguez, C. M., Arredondo, G. S., Bosques, F. P., Zertuche, T. M. & Torre L. F. (2016) Unusual presentation of Gilbert disease with high levels of unconjugated bilirubin: report of two cases. Rev. esp. enferm. dig. 108(4): 228-230.

Foulk, W. T., Butt, H. R., Owen, C. A., Withcomb, F. F. & Mason, H. L. (1959). Constitutional hepatic dysfunction (Gilbert disease): its natural history and related syndromes. Medicine (Baltimore). 38(1):25-46.

Fretzayas, A., Moustaki, M., Liapi, O. & Karpathios, T. (2012). Gilbert syndrome. Eur J Pediatr. 171(1): 11-5.

Gazzin, S., Masutti, F., Vitek, L. & Tiribelli, C. (2017). The molecular basis of jaundice: An old symptom revisited. Liver International. 37(8):1094-1102.

Gollan J, Bateman C, Billing B. Effect of dietary composition on the unconjugated hyperbilirubinaemia of Gilbert's syndrome. Gut. 17(5):335-340.

Hauser, S. C. & Holland, J. (1992). Bilirubin metabolism and hyperbilirrubinaemic disorders. In: Millward-Sadler GH, Wright R, Arthur MJ, eds. Wright's liver and biliary disease. London: W.B. Saunders. 318-351.

Hinds, T., Hosick, P., Chen, S., Tukey, R., Hankins, M. & Nestor-Kalinoski, A. et al. (2017). Mice with hyperbilirubinemia due to Gilbert’s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα. American Journal of Physiology-Endocrinology and Metabolism. 312(4):E244-E252.

Horsfall, L., Nazareth, I., Pereira, S. & Petersen, I. (2013). Gilbert's syndrome and the risk of death: a population-based cohort study. Journal of Gastroenterology and Hepatology. n/a-n/a.

Horsfall, L., Zeitlyn, D., Tarekegn, A., Bekele, E., Thomas, M. & Bradman, N. et al. (2011). Prevalence of Clinically Relevant UGT1A Alleles and Haplotypes in African Populations. Annals of Human Genetics. 75(2):236-246.

Jamwal, M., Aggarwal, A., Kumar, V., Sharma, P., Sachdeva, M. & Bansal, D. et al. (2016). Disease-modifying influences of coexistent G6PD-deficiency, Gilbert syndrome and deletional alpha thalassemia in hereditary spherocytosis: A report of three cases. Clinica Chimica Acta. 458:51-54.

Jenko-Pražnikar, Z., Petelin, A., Jurdana, M. & Žiberna, L. (2013). Serum bilirubin levels are lower in overweight asymptomatic middle-aged adults: An early indicator of metabolic syndrome? Metabolism. 62(7):976-985.

Kadakol, A., Ghosh, S., Sappal, B., Sharma, G., Chowdhury, J. & Chowdhury, N. (2000). Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: Correlation of genotype to phenotype. Human Mutation. 16(4):297-306.

Kamal, S., Salam, A. A., Shahid, K. & Huda, H. (2015). Patterns and Genetic Polymorphisms in Unconjugated Hyperbilirubinemia (Gilbert Syndrome). Pediatrics. 135:2014–3330.

Kaplan, M., Wong, R. & Stevenson, D. (2017). Heme oxygenase-1 promoter polymorphisms: do they modulate neonatal hyperbilirubinemia? Journal of Perinatology. 37(8):901-905.

Kathemann, S., Lainka, E., Baba, H., Hoyer, P. & Gerner, P. (2012). Gilbert’s syndrome - a frequent cause of unconjugated hyperbilirubinemia in children after orthotopic liver transplantation. Pediatric Transplantation. 16(2):201-204.

Kawase, A., Yamamoto, T., Egashira, S. & Iwaki, M. (2016). Stereoselective Inhibition of Methotrexate Excretion by Glucuronides of Nonsteroidal Anti-inflammatory Drugs via Multidrug Resistance Proteins 2 and 4. J Pharmacol Exp Ther. 356(2):366-74.

Kundur, A., Singh, I. & Bulmer, A. (2015). Bilirubin, platelet activation and heart disease: A missing link to cardiovascular protection in Gilbert's syndrome? Atherosclerosis. 239(1):73-84.

Kutsuno, Y., Itoh, T., Tukey, R.H. & Fujiwara, R. (2014). Glucuronidation of drugs and drug-induced toxicity in humanized UDP-glucuronosyltransferase 1 mice. Drug Metab Dispos. 42(7):1146-52.

Liaury, K., Miyaoka, T., Tsumori, T., Furuya, M., Hashioka, S. & Wake, R. et al. (2014). Minocycline improves recognition memory and attenuates microglial activation in Gunn rat: A possible hyperbilirubinemia-induced animal model of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 50:184-190.

Marques, S. C. & Ikediobi, O. N. (2010). The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions. Hum Genomics. 4(4):238-49.

Marschall, H., Krawczyk, M., Grünhage, F,, Katsika, D., Einarsson, C. & Lammert, F. (2013). Gallstone disease in Swedish twins is associated with the Gilbert variant of UGT1A1. Liver International. 33(6):904-908.

Martelli, A. (2010). Síntese e metabolismo da bilirrubina e fisiopatologia da hiperbilirrubinemia associados à Síndrome de Gilbert: revisão de literatura. Rev Med Minas Gerais 22(2): 216-220. <>. Acesso em: 14/11/2017.

Maruhashi, T., Soga, J., Fujimura, N., Idei, N., Mikami, S., Iwamoto, Y., Kajikawa, M., Matsumoto, T., Kihara, Y., Chayama, K., Noma, K., Nakashima, A., Tomiyama, H., Takase, B., Yamashina, A. & Higashi, Y. (2012) Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation. 126(5):598-603.

Maruo, Y., Nakahara, S., Yanagi, T., Nomura, A., Mimura, Y., Matsui, K., Sato, H. & Takeuchi, Y. (2016). Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome. J Gastroenterol Hepatol. 31(2):403-8.

Mölzer, C., Wallner, M., Kern, C., Tosevska, A., Schwarz, U. & Zadnikar, R. et al. (2016). Features of an altered AMPK metabolic pathway in Gilbert’s Syndrome, and its role in metabolic health. Scientific Reports. 6(1).

Muraca, M., Fevery, J. & Blanckaert, N. (1987). Relationships between serum bilirubins and production and conjugation of bilirubin. Gastroenterology. 92(2):309-317.

Murthy et al. (2001). Rifampin. in Diagnosing Gilbert’s Syndrome. Am. Coll. of Gastroenterology. 96 (4): 1150–1154.

Owens, D. & Evans, J. (1975). Population studies on Gilbert's syndrome. Journal of Medical Genetics. 12:152.

Owens, D. & Sherlock, S. (1973). Diagnosis of Gilbert's Syndrome: Role of Reduced Caloric Intake Test. British Medical Journal. 3, 559-563.

Owens, D. & Sherlock, S. (1973). Reduced Caloric Intake and Nicotinic Acid Provocation Tests in the Diagnosis of Gilbert's Syndrome. British Medical Journal; 3:559.

Powell, L., Hemingway, E., Billing, B. & Sherlock, S. (1967). Idiopathic Unconjugated Hyperbilirubinemia (Gilbert's Syndrome). New England Journal of Medicine. 277(21):1108-1112.

Radoi, V. E., Ursu, R. I., Poenaru, E., Arsene, C., Bohiltea, C. L. & Bohiltea, R. (2017). Frequency of the UGT1A1*28 polymorphism in a Romanian cohort of Gilbert syndrome individuals. Journal of Gastrointestinal and Liver Diseases. 26(1).

Rollinghoff, W., Paumgartener, G. & Preisg, R. (1981). Nicotinic acid test in the diagnosis of Gilbert's syndrome: correlation with bilirubin clearance. Gut. 22:663-668.

Rowland, R., O’Hara, G. A., Hamill, M., Poulton, I. D., Donaldson, H., Dinsmore, L. & McShane, H. (2015). Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines. Human Vaccines & Immunotherapeutics. 1741–1751.

Shiu, T., Huang, H., Lin, H., Shih, Y., Chu, H. & Chang, W. et al. (2015). Restriction fragment length polymorphism effectively identifies exon 1 mutation of UGT1A1 gene in patients with Gilbert's Syndrome. Liver International. 35(8):2050-2056.

Sieg, A., Stiehl, A., Raedsch, R., Ullrich, D., Messmer, B. & Kommerell, B. (1986). Gilbert’s syndrome: diagnosis by typical serum bilirubin pattern. Clinica Chimica Acta. 154:41-48.

Smith, P., Middleton, J. & Williams, R. (1967). Studies on the familial incidence and clinical history of patients with chronic unconjugated hyperbilirubinaemia. Gut. 8(5):449-453.

Stender, S., Frikke-Schmidt, R., Nordestgaard, B., Grande, P. & Tybjaerg-Hansen, A. (2012). Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis. Journal of Internal Medicine. 273(1):59-68.

Strassburg C. Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Practice & Research Clinical Gastroenterology. 2010;24(5):555-571.

Sullivan, J. I. & Rockey, D. C. (2017). Diagnosis and evaluation of hyperbilirubinemia. Curr Opin Gastroenterol. 33(3):164-170.

Tapan, S., Karadurmus, N., Dogru, T., Ercin, C., Tasci, I. & Bilgi, C. et al. (2011). Decreased small dense LDL levels in Gilbert's syndrome. Clinical Biochemistry. 44(4):300-303.

Te, H. S., Schiano, T. D. & Das, T. et al. (2000). Donor liver uridine diphosphate (UDP) -glucuronosyltransferase -1A1 deficiency causing Gilbert’s syndrome in liver transplant recipients. Transplantation. 69:882-6.

Thomsen, H. F., Hardt, F. & Juhl, E. (1981). Diagnosis of Gilbert’s syndrome. Reliability of the caloric restriction and phenobarbital stimulation tests. Scand. J. Gastroenr. 16, 699-703.

Tosevska, A., Moelzer, C., Wallner, M., Janosec, M., Schwarz, U. & Kern, C. et al. (2016). Longer telomeres in chronic, moderate, unconjugated hyperbilirubinaemia: insights from a human study on Gilbert’s Syndrome. Scientific Reports. 6(1).

Wallner, M., Marculescu, R., Doberer, D., Wolzt, M., Wagner, O. & Vitek, L. et al. (2013). Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clinical Science. 125(5):257-264.

Wallner, M., Bulmer, A. C., Mölzer, C., Müllner, E., Marculescu, R., Doberer, D., Wolzt, M., Wagner, O. F. & Wagner, K. H. (2013). Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome. Eur J Clin Invest. 43(9):912-9.

Watson, K. J. R. & Gollan, J. L. (1976). Gilbert's syndrome. Bailliere's Clinical Gastroenterology. 3(2): 337-355.

Wong, R. J., Bhutani, V. K. & Abrams, S. A. (2015). Pathogenesis and etiology of unconjugated hyperbilirubinemia in the newborn. Up to Date.

Žaja, O., Tiljak, M. K., Štefanović, M., Tumbri, J. & Jurčić, Z. (2014). Correlation of UGT1A1 TATA-box polymorphism and jaundice in breastfed newborns-early presentation of Gilbert's syndrome. J Matern Fetal Neonatal Med. 27(8):844-50.



How to Cite

VETURIANO, M. S. .; CARVALHO FILHO, E. A. de .; RAMOS, M. G. C. . Gilbert syndrome: Literature review directed at diagnostic methods. Research, Society and Development, [S. l.], v. 12, n. 4, p. e6412440829, 2023. DOI: 10.33448/rsd-v12i4.40829. Disponível em: Acesso em: 29 may. 2023.



Health Sciences